Page last updated: 2024-08-23

isosorbide-5-mononitrate and Erectile Dysfunction

isosorbide-5-mononitrate has been researched along with Erectile Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kloner, RA1
Bellamy, GR; Csanady, M; Edes, I; Gillies, H; Jackson, G; Keltai, M; Lisa, L; Widimsky, P1

Reviews

1 review(s) available for isosorbide-5-mononitrate and Erectile Dysfunction

ArticleYear
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
    Circulation, 2004, Nov-09, Volume: 110, Issue:19

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents

2004

Trials

1 trial(s) available for isosorbide-5-mononitrate and Erectile Dysfunction

ArticleYear
Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction.
    The journal of sexual medicine, 2005, Volume: 2, Issue:3

    Topics: Adult; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Erectile Dysfunction; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents

2005